Review



dermal neonatal human lymphatic microvascular endothelial cells, lecs cc-2812  (Cambrex)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cambrex dermal neonatal human lymphatic microvascular endothelial cells, lecs cc-2812
    Dermal Neonatal Human Lymphatic Microvascular Endothelial Cells, Lecs Cc 2812, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/neonatal+human+dermal+lymphatic+microvascular+endothelial+cells++lecs+/pmc03287291-63-10-13
    Average 90 stars, based on 1 article reviews
    dermal neonatal human lymphatic microvascular endothelial cells, lecs cc-2812 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Endothelial Nitric Oxide Synthase Mediates Lymphangiogenesis and Lymphatic Metastasis
    Article Snippet: Neonatal Human Dermal LECs were obtained from Cambrex.



    Similar Products

    primary neonatal human dermal-derived lecs (hlecs; hmvec-dlyneo, cc-2812)  (Lonza)
    90
    Lonza primary neonatal human dermal-derived lecs (hlecs; hmvec-dlyneo, cc-2812)
    Primary Neonatal Human Dermal Derived Lecs (Hlecs; Hmvec Dlyneo, Cc 2812), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+microvascular+endothelial+cells/pm37486193-48-0-8
    Average 90 stars, based on 1 article reviews
    primary neonatal human dermal-derived lecs (hlecs; hmvec-dlyneo, cc-2812) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    human dermal microvascular endothelial cells, neonatal and pooled (lecs; >90)  (Lonza)
    90
    Lonza human dermal microvascular endothelial cells, neonatal and pooled (lecs; >90)
    Human Dermal Microvascular Endothelial Cells, Neonatal And Pooled (Lecs; >90), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+microvascular+endothelial+cells/pmc09266834-540-7-13
    Average 90 stars, based on 1 article reviews
    human dermal microvascular endothelial cells, neonatal and pooled (lecs; >90) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    human neonatal dermal lecs hmvec-dlyneo-der  (Lonza)
    90
    Lonza human neonatal dermal lecs hmvec-dlyneo-der
    Human Neonatal Dermal Lecs Hmvec Dlyneo Der, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+microvascular+endothelial+cells/pmc05358488-198-0-5
    Average 90 stars, based on 1 article reviews
    human neonatal dermal lecs hmvec-dlyneo-der - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    human neonatal dermal lecs (hmvec-dlyneo-der  (Lonza)
    90
    Lonza human neonatal dermal lecs (hmvec-dlyneo-der
    Human Neonatal Dermal Lecs (Hmvec Dlyneo Der, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+neonatal+microdermal+lecs/pmc05358488-249-0-5
    Average 90 stars, based on 1 article reviews
    human neonatal dermal lecs (hmvec-dlyneo-der - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    human neonatal dermal lymphatic endothelial cells (lec  (AngioBio Inc)
    90
    AngioBio Inc human neonatal dermal lymphatic endothelial cells (lec
    Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
    Human Neonatal Dermal Lymphatic Endothelial Cells (Lec, supplied by AngioBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+dermal+lymphatic+endothelial+cells++dlec+/pmc07657111-66-0-10
    Average 90 stars, based on 1 article reviews
    human neonatal dermal lymphatic endothelial cells (lec - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    neonatal human dermal lymphatic microvascular endothelial cells lec: hmvec-dly cc-2812  (Lonza)
    90
    Lonza neonatal human dermal lymphatic microvascular endothelial cells lec: hmvec-dly cc-2812
    Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
    Neonatal Human Dermal Lymphatic Microvascular Endothelial Cells Lec: Hmvec Dly Cc 2812, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+microvascular+endothelial+cells/pmc03445762-34-2-11
    Average 90 stars, based on 1 article reviews
    neonatal human dermal lymphatic microvascular endothelial cells lec: hmvec-dly cc-2812 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    dermal neonatal human lymphatic microvascular endothelial cells, lecs cc-2812  (Cambrex)
    90
    Cambrex dermal neonatal human lymphatic microvascular endothelial cells, lecs cc-2812
    Suppression of vascular endothelial growth factor <t>(VEGF)‐C‐driven</t> <t>lymphatic</t> endothelial cell <t>(LEC)</t> proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).
    Dermal Neonatal Human Lymphatic Microvascular Endothelial Cells, Lecs Cc 2812, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/neonatal+human+dermal+lymphatic+microvascular+endothelial+cells++lecs+/pmc03287291-63-10-13
    Average 90 stars, based on 1 article reviews
    dermal neonatal human lymphatic microvascular endothelial cells, lecs cc-2812 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    primary neonatal human dermal lecs  (Lonza)
    90
    Lonza primary neonatal human dermal lecs
    A , Prostatic LEC tube length at 4.5 hours post VEGF-C treatment was quantified using ImageJ. VEGF-C significantly increased the number of tubes formed compared to vehicle control. Data expressed as mean±s.e.m., n = 3, *** P <0.001 using One-way ANOVA, Bonferroni post-analysis. B , Western blotting analysis of VEGFR-2 and VEGFR-3 expression in <t>lung,</t> <t>neonatal</t> dermis and prostate <t>LECs.</t> β-tubulin was used as a loading control.
    Primary Neonatal Human Dermal Lecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+neonatal+microdermal+lecs/pmc03382126-164-0-13
    Average 90 stars, based on 1 article reviews
    primary neonatal human dermal lecs - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    neonatal human dermal lymphatic microvascular endothelial cells (lec)  (Lonza)
    90
    Lonza neonatal human dermal lymphatic microvascular endothelial cells (lec)
    A , Prostatic LEC tube length at 4.5 hours post VEGF-C treatment was quantified using ImageJ. VEGF-C significantly increased the number of tubes formed compared to vehicle control. Data expressed as mean±s.e.m., n = 3, *** P <0.001 using One-way ANOVA, Bonferroni post-analysis. B , Western blotting analysis of VEGFR-2 and VEGFR-3 expression in <t>lung,</t> <t>neonatal</t> dermis and prostate <t>LECs.</t> β-tubulin was used as a loading control.
    Neonatal Human Dermal Lymphatic Microvascular Endothelial Cells (Lec), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/neonatal+human+dermal+lecs/human+microvascular+endothelial+cells/pm21040746-85-0-8
    Average 90 stars, based on 1 article reviews
    neonatal human dermal lymphatic microvascular endothelial cells (lec) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Suppression of vascular endothelial growth factor (VEGF)‐C‐driven lymphatic endothelial cell (LEC) proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).

    Journal: Cancer Science

    Article Title: Suppression of lymph node and lung metastases of endometrial cancer by muscle‐mediated expression of soluble vascular endothelial growth factor receptor‐3

    doi: 10.1111/cas.12184

    Figure Lengend Snippet: Suppression of vascular endothelial growth factor (VEGF)‐C‐driven lymphatic endothelial cell (LEC) proliferation by conditioned medium of soluble vascular endothelial growth factor receptor‐3 (sVEGFR‐3)‐expressing cells. Cells were plated at 5 × 103 cells/well in 96‐well plates, and 50% sVEGFR‐3‐conditioned medium or luciferase‐conditioned medium was added with 100 ng/mL recombinant human VEGF‐C. The number of LEC with 50% sVEGFR‐3‐conditioned medium (b) was clearly smaller than that with control (a). The cells were counted by colorimetric assay 48 h after plating. Each bar represents the mean ± SD. (*P < 0.01) (c).

    Article Snippet: Human neonatal dermal lymphatic endothelial cells (LEC) were purchased from AngioBio (Del Mar, CA, USA) and maintained in EGM‐MV2 BulletKit (Cambrex, East Rutherford, NJ, USA) supplemented with 10% inactivated FCS at 37°C in a 5% CO 2 atmosphere.

    Techniques: Expressing, Luciferase, Recombinant, Colorimetric Assay

    A , Prostatic LEC tube length at 4.5 hours post VEGF-C treatment was quantified using ImageJ. VEGF-C significantly increased the number of tubes formed compared to vehicle control. Data expressed as mean±s.e.m., n = 3, *** P <0.001 using One-way ANOVA, Bonferroni post-analysis. B , Western blotting analysis of VEGFR-2 and VEGFR-3 expression in lung, neonatal dermis and prostate LECs. β-tubulin was used as a loading control.

    Journal: PLoS ONE

    Article Title: Vascular Endothelial Growth Factor Receptor-3 Directly Interacts with Phosphatidylinositol 3-Kinase to Regulate Lymphangiogenesis

    doi: 10.1371/journal.pone.0039558

    Figure Lengend Snippet: A , Prostatic LEC tube length at 4.5 hours post VEGF-C treatment was quantified using ImageJ. VEGF-C significantly increased the number of tubes formed compared to vehicle control. Data expressed as mean±s.e.m., n = 3, *** P <0.001 using One-way ANOVA, Bonferroni post-analysis. B , Western blotting analysis of VEGFR-2 and VEGFR-3 expression in lung, neonatal dermis and prostate LECs. β-tubulin was used as a loading control.

    Article Snippet: Primary neonatal human dermal LECs and primary human lung LECs were purchased from Lonza (Switzerland) and maintained in EGMTM-2 MV medium (Lonza).

    Techniques: Control, Western Blot, Expressing